Advertisement
    In the last hour
    In the last 2 hours
    In the last 4 hours
    In the last 6 hours
    Earlier today
    Yesterday
    In the last 7 days
    CRISPR Stock Rallies Following Analyst Upgrade Wall Street Pit14:20 14-Feb-25
    The P3 edit eLife14:39 12-Feb-25
    In the last month
    Experts to NSA: probe gene edited seeds The Nation, Nigeria15:25 11-Feb-25
    Degrading DNA with Cascade-Cas3 Addgene14:16 11-Feb-25
    Vertex Reports Fourth Quarter and Full Year 2024 Financial Results Business Wire (Press Release)21:07 10-Feb-25
    Weekly Dose of Optimism #130 Not Boring13:28 7-Feb-25
    Broken String Biosciences Launches INDUCE-seq Catalyst Program Genetic Engineering and Biotechnology News12:37 6-Feb-25
    From development to tumorigenesis: novel human brain organoids Behavioural and Social Sciences at Nature Research10:45 5-Feb-25
    Gene editing is not the same as GMO Food Safety News05:10 5-Feb-25
    AgBio Companies Embrace Gene Editing for Stronger Food Future Genetic Engineering and Biotechnology News13:04 3-Feb-25
    AI-Enabled Gene Editing Produces Fewer Off-Target Outcomes Genetic Engineering and Biotechnology News13:04 3-Feb-25
    AAV Delivered NanoCas CRISPR System Edits Muscle in Non-Human Primates Genetic Engineering and Biotechnology News11:33 3-Feb-25
    UK approval for gene therapy for severe sickle cell disease British Society for Haematology10:46 3-Feb-25
    NHS England to offer Casgevy for sickle cell disease patients Pharmaceutical Technology12:29 31-Jan-25
    Generating sterile Anopheles mosquitoes to combat malaria transmission Behavioural and Social Sciences at Nature Research05:29 31-Jan-25
    Next-Gen Cas12a System Enables Precise Single and Multiplexed Gene Editing in Cancer Genetic Engineering and Biotechnology News03:04 31-Jan-25
    Defra urged to push ahead with gene editing for livestock Farmers Weekly Interactive15:29 30-Jan-25
    view more headlines
    19 Feb 16:54

    About our CRISPR/Gene Editing news

    Latest news on CRISPR/Gene Editing, covering breakthroughs, applications, ethics, regulations, and implications for health, agriculture, and biotechnology. Stay informed on this revolutionary technology.

    CRISPR/Cas9, the groundbreaking gene-editing tool, has revolutionised the field of genetics and biotechnology since its discovery in 2012. Developed by scientists Jennifer Doudna and Emmanuelle Charpentier, who were awarded the Nobel Prize in Chemistry in 2020, CRISPR allows for precise, efficient, and cost-effective editing of DNA sequences in living organisms.

    The potential applications of CRISPR are vast, spanning healthcare, agriculture, and beyond. In medicine, CRISPR holds promise for treating genetic disorders, developing novel therapies for diseases like cancer and HIV, and even potentially enhancing human traits. Recent breakthroughs include the first clinical trials of CRISPR-based treatments for sickle cell anemia and beta-thalassemia, as well as advancements in using CRISPR to target antibiotic-resistant bacteria.

    In agriculture, CRISPR is being explored to develop more resilient, nutritious, and sustainable crops, as well as to create disease-resistant livestock. Companies like Corteva Agriscience and Calyxt are at the forefront of these efforts. However, the use of CRISPR in agriculture has also sparked debates about GMO regulations, labelling, and public acceptance.

    Despite its immense potential, CRISPR also raises significant ethical and societal concerns. The prospect of human germline editing, which could alter the genetic makeup of future generations, has been particularly controversial. In 2018, Chinese scientist He Jiankui claimed to have created the world's first gene-edited babies, sparking global outcry and calls for stricter oversight. Organizations like the World Health Organization and the National Academies of Sciences have issued guidelines and recommendations for the responsible development and governance of gene editing.

    Stay up-to-date on the latest CRISPR/Gene Editing news with our dedicated feed, covering everything from cutting-edge research and clinical trials to policy developments and societal debates, as this transformative technology continues to shape our future.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.